NCR100 / Nuwacell Biotech - LARVOL DELTA

A Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution (clinicaltrials.gov) - P1 | N=6 | Not yet recruiting | Sponsor: Nuwacell Biotechnologies Co., Ltd.

New P1 trial • Immunology • Osteoarthritis • Pain • Rheumatology

A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA） (clinicaltrials.gov) - P1/2 | N=162 | Not yet recruiting | Sponsor: Nuwacell Biotechnologies Co., Ltd.

New P1/2 trial • Immunology • Osteoarthritis • Pain • Rheumatology

A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Nuwacell Biotechnologies Co., Ltd. | Initiation date: Oct 2023 ➔ Jan 2024

Stroma • Trial initiation date • Immunology • Osteoarthritis • Pain • Rheumatology

NCRD: A non-redundant comprehensive database for detecting antibiotic resistance genes. (PubMed, iScience) - "We identified the homologous proteins of NRD from Non-redundant Protein Database (NR) and the Protein DataBank Database (PDB) and clustered them to establish a non-redundant comprehensive antibiotic resistance genes database (NCRD) with similarities of 100% (NCRD100) and 95% (NCRD95). To demonstrate the advantages of NCRD, we compared it with other databases by using metagenome datasets. Results revealed its strong ability in detecting potential ARGs."

Journal

A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Nuwacell Biotechnologies Co., Ltd.

New P1 trial • Stroma • Immunology • Osteoarthritis • Pain • Rheumatology